States With Age Restriction On OTC DXM Sales Number 17 – And Counting
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Pennsylvania is 17th US state to limit sales of dextromethorphan OTCs to consumers 18 and older because teenagers' abuse of the ingredient for intoxicating effect remains a common problem.
You may also be interested in...
HBW Market Roundup: Prop 65 Amendment Off, Enforcement Discretion Asked For Label Compliance, More
California withdraws Prop 65 proposal to clarify when and how average concentrations can be calculated for a listed chemical due to deadline; trade groups ask FDA for enforcement discretion on compliance date for Nutrition and Supplement Facts labels rules; FDA published list of necessary records for FSVP applications; and use of OTC analgesics grows in teen suicide attempts.
Health Market News: DXM Sales Age-Restriction Bill Filed, E-Cigarettes Top NRTs In UK Trial
Resp. Matsui, Johnson again introduce bill for national age-18 requirement for OTC DXM sales; E-Cigarettes top NRTs for smoking cessation efficacy in UK trial.
Two States Require Industry To Pay For Ongoing Drug Take-Back Programs
Consumer Healthcare Products Association looks to stem expansion of state-mandated drug take-back programs with programs that use existing facilities and infrastucture and don't require industry funidng, says state affairs VP Carlos Gutierrez. State bills limiting sales of DXM to minors and expansion of the NPLEx system to track PSE sales also are on CHPA’s radar.